Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume XXI No. 11 - August 11, 2014

When Competing Hospitals Come Together

MANY ANATOMIC PATHOLOGY GROUPS that have enjoyed contracts with one or more hospitals for decades now find those relationships challenged or disturbed by the spate of mergers and acquisitions happening with hospitals and health systems. This trend will carry forward for several more years. At least two distinct forces are encouraging hospitals and health systems …

When Competing Hospitals Come Together Read More »

To access this post, you must purchase The Dark Report.

Ignoring Lab Industry, Theranos Goes Its Way

CEO SUMMARY: With each passing month, Theranos pulls open the curtain a bit more on its business structure and its market growth plans. Its clinical lab tests are now offered in Walgreens pharmacies in Palo Alto, California, and Phoenix, Arizona. Recent news coverage in Fortune and USAToday disclosed that company officials—based on stock sales to …

Ignoring Lab Industry, Theranos Goes Its Way Read More »

To access this post, you must purchase The Dark Report.

My Visit to Walgreens for Theranos Lab Tests

CEO SUMMARY: One of the biggest unknowns in the lab testing industry today is Theranos, the lab testing company based in Palo Alto, California. It says its proprietary technology is poised to transform the lab testing experience for patients and physicians. It says it can perform hundreds of lab tests, using a finger stick collection …

My Visit to Walgreens for Theranos Lab Tests Read More »

To access this post, you must purchase The Dark Report.

Incyte to Develop New Ways For Pathologists to Add Value

CONSOLIDATION OF PRIVATE PRACTICE PATHOLOGY GROUPS in Washington State has been ongoing. Because of their acquisitions, CellNetix and Incyte Diagnostics are now the state’s two largest pathology groups. The next challenge for these two pathology super-groups will be developing new ways to add value to a healthcare system moving away from fee-for-service reimbursement and to …

Incyte to Develop New Ways For Pathologists to Add Value Read More »

To access this post, you must purchase The Dark Report.

NorDx CEO Shares Five Rules Critical to every Lab’s Success

CEO SUMMARY: To meet the financial challenges of healthcare today, clinical labs and pathology groups can follow the five classic lab rules of success. However, as noted by Stan Schofield, CEO of NorDx Laboratories in Scarborough, Maine, the “old school” methods need to be replaced by “new school” strategies. In this conclusion to a two-part …

NorDx CEO Shares Five Rules Critical to every Lab’s Success Read More »

To access this post, you must purchase The Dark Report.

FDA Notifies Congress that It Will Regulate LDTs

CEO SUMMARY: Since 2006, the FDA has said it has the authority to regulate lab-developed tests, but it has held off on doing so. Now the agency says it’s time, defining LDTs as being, “designed, manufactured, and used within a single laboratory. LDTs include some genetic tests and tests that are used by healthcare professionals …

FDA Notifies Congress that It Will Regulate LDTs Read More »

To access this post, you must purchase The Dark Report.

August 11, 2014 “Intelligence: Late Breaking Lab News”

There is a new case of crime involving a private pathology group practice. In Stockton, California, the Stockton Record reported on August 9 that pathologist Elvira Milano, M.D., was expected to post bond and be released from jail on that date. She faces charges of embezzlement while serving as chief financial officer of Delta Pathology …

August 11, 2014 “Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;